A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.

Familial Alzheimer's disease (fAD) results from mutations in the amyloid precursor protein (APP) and presenilin (PSEN1 and PSEN2) genes. Here we leveraged recent advances in induced pluripotent stem cell (iPSC) and CRISPR/Cas9 genome editing technologies to generate a panel of isogenic knockin human iPSC lines carrying APP and/or PSEN1 mutations. Global transcriptomic and translatomic profiling revealed that fAD mutations have overlapping effects on the expression of AD-related and endocytosis-associated genes. Mutant neurons also increased Rab5+ early endosome size. APP and PSEN1 mutations had discordant effects on Aβ production but similar effects on APP β C-terminal fragments (β-CTFs), which accumulate in all mutant neurons. Importantly, endosomal dysfunction correlated with accumulation of β-CTFs, not Aβ, and could be rescued by pharmacological modulation of β-secretase (BACE). These data display the utility of our mutant iPSCs in studying AD-related phenotypes in a non-overexpression human-based system and support mounting evidence that β-CTF may be critical in AD pathogenesis.

• Publication year

  2019

• Venue

  Neuron

• Publication date

  2019-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuron.2019.07.010PMID 31416668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence Analysis

  2020cited by this paper
• TMEM30A is a candidate interacting partner for the β-carboxyl-terminal fragment of amyloid-β precursor protein in endosomes

  2018cited by this paper
• Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease

  2018cited by this paper
• CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2N141I neurons

  2017cited by this paper
• BACE inhibitor bust in Alzheimer trial

  2017cited by this paper
• Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer's Disease.

  2017cited by this paper
• Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions.

  2017cited by this paper
• Precise and efficient scarless genome editing in stem cells using CORRECT

  2017cited by this paper
• Presenilin-1 mutations and Alzheimer’s disease

  2017cited by this paper
• PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease

  2017cited by this paper
• Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs

  2017cited by this paper
• ggplot2 - Elegant Graphics for Data Analysis (2nd Edition)

  2017cited by this paper
• CLIP Tool Kit (CTK): a flexible and robust pipeline to analyze CLIP sequencing data

  2016cited by this paper
• Genes associated with Alzheimer’s disease: an overview and current status

  2016cited by this paper
• Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes

  2016cited by this paper
• Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

  2016cited by this paper
• Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations.

  2016cited by this paper
• PAPERCLIP Identifies MicroRNA Targets and a Role of CstF64/64tau in Promoting Non-canonical poly(A) Site Usage.

  2016cited by this paper
• Alzheimer's disease

  2016cited by this paper
• The modeling of Alzheimer's disease by the overexpression of mutant Presenilin 1 in human embryonic stem cells.

  2016cited by this paper
• Restricted Location of PSEN2/γ-Secretase Determines Substrate Specificity and Generates an Intracellular Aβ Pool.

  2016cited by this paper
• A systematic review of familial Alzheimer's disease: Differences in presentation of clinical features among three mutated genes and potential ethnic differences.

  2016cited by this paper
• Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.

  2016cited by this paper
• Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9

  2016cited by this paper
• Complement and microglia mediate early synapse loss in Alzheimer mouse models

  2016cited by this paper
• Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

  2015cited by this paper
• Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons

  2015cited by this paper
• APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons

  2015cited by this paper
• Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease

  2015cited by this paper
• Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors

  2014cited by this paper
• HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism.

  2014cited by this paper
• The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.

  2014cited by this paper
• Dysregulation of protein trafficking in neurodegeneration

  2014cited by this paper
• Effect of potent γ-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers.

  2014cited by this paper
• Molecular Mechanisms of Alzheimer’s Disease Protection by the A673T Allele of Amyloid Precursor Protein

  2014cited by this paper
• Development and mechanism of γ-secretase modulators for Alzheimer's disease.

  2013cited by this paper
• The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells.

  2013cited by this paper
• Exact and Approximate Area-Proportional Circular Venn and Euler Diagrams

  2012cited by this paper
• Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of γ-secretase activity in endogenous amyloid-β generation.

  2012cited by this paper
• The mechanism of γ-Secretase dysfunction in familial Alzheimer disease

  2012cited by this paper
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• Trafficking and proteolytic processing of APP.

  2012cited by this paper
• Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1.

  2011cited by this paper
• Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

  2011cited by this paper
• Modeling familial Alzheimer's disease with induced pluripotent stem cells.

  2011cited by this paper
• Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds*

  2011cited by this paper
• Cutadapt removes adapter sequences from high-throughput sequencing reads

  2011cited by this paper
• Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.

  2010cited by this paper
• γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment

  2009cited by this paper
• Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition

  2009cited by this paper
• Mutations in amyloid precursor protein affect its interactions with presenilin/gamma-secretase.

  2009cited by this paper
• Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia

  2009cited by this paper
• Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling

  2009cited by this paper
• Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.

  2008cited by this paper
• APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

  2006cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

  2006cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production

  2002cited by this paper
• Endocytic Pathway Abnormalities Precede Amyloid β Deposition in Sporadic Alzheimer’s Disease and Down Syndrome

  2000cited by this paper
• DGGE method for the mutational analysis of the coding and proximal promoter regions of the Alzheimer's disease presenilin‐1 gene: Two novel mutations

  1999cited by this paper
• Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path

  1998cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43).

  1997cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

  1995cited by this paper
• The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families

  1995cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

  1992cited by this paper
• Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14

  1992cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3

  1992cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

  1988cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

  1987cited by this paper
• The genetic defect causing familial Alzheimer's disease maps on chromosome 21.

  1987cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper
• Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

  1986cited by this paper

• RIN3 mutations impairing binding of the Alzheimer’s disease–associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology

  2026cites this paper
• Therapeutic and preventive strategies based on the maladaptive plasticity hypothesis for Alzheimer’s disease

  2026cites this paper
• Spatial Neurobiology in Brain Organoids Using Mass Spectrometry Imaging-Based Multiomics Approach.

  2026cites this paper
• CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges

  2026cites this paper
• Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer’s models

  2026cites this paper
• Autophagy Activators Normalize Aberrant Tau Proteostasis and Rescue Synapses in Human Familial Alzheimer's Disease iPSC-Derived Cortical Organoids.

  2026cites this paper
• SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients.

  2026cites this paper
• HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs.

  2026cites this paper
• Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model

  2026cites this paper
• A C. elegans model of familial Alzheimer's disease shows age-dependent synaptic degeneration independent of amyloid β-peptide.

  2026cites this paper
• The role of gut microbiota dysbiosis in drug-induced brain injury: mechanisms and therapeutic implications

  2025cites this paper
• Synthesis of 18F-Labeled FC-119S and Its Tosyl Precursor.

  2025cites this paper
• Multi-omics analyses of early-onset familial Alzheimer's disease and Sanfilippo syndrome zebrafish models reveal commonalities in disease mechanisms.

  2025cites this paper
• Autophagy activators normalize aberrant Tau proteostasis and rescue synapses in human familial Alzheimer’s disease iPSC-derived cortical organoids

  2025cites this paper
• AP2A1 activates Rab7 to promote axonal autophagosome transport and slow the progression of Alzheimer’s disease

  2025cites this paper
• CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density.

  2025cites this paper
• A unique subpopulation of wild-type neurons recapitulating familial Alzheimer’s disease phenotypes

  2025cites this paper
• Hyperactivation of RAB5 disrupts the endosomal Rab cascade leading to endolysosomal dysregulation in Down syndrome: A necessary role for increased APP gene dose

  2025cites this paper
• Targeting RPSA to modulate endosomal trafficking and amyloidogenesis in genetic Alzheimer's disease.

  2025cites this paper
• Humanized rodent models of neurodegenerative diseases and other brain disorders.

  2025cites this paper
• Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease

  2025cites this paper
• The Alzheimer’s-Associated SORL1 p.Y1816C Variant Impairs APP Sorting, Axonal Trafficking, and Neuronal Activity in iPSC-Derived Brain Models

  2025cites this paper
• CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer’s Disease

  2025cites this paper
• Nanotechnology Approaches in Neurodegenerative Diseases

  2025cites this paper
• Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer's disease.

  2025cites this paper
• Mechanisms of the Pathogenesis of Alzheimer’s Disease: The Role of the Basal Forebrain

  2025cites this paper
• BACE1 as an early biomarker and its relevance to risk factors for Alzheimer's disease.

  2025cites this paper
• Non-genetic neuromodulation with graphene optoelectronic actuators for disease models, stem cell maturation, and biohybrid robotics

  2025cites this paper
• Impaired BDNF-TrkB trafficking and signalling in Down syndrome basal forebrain neurons

  2025cites this paper
• Next-Generation Biosensor Technologies for Alzheimer's Disease: Innovations in Diagnosis, Monitoring, and Treatment.

  2025cites this paper
• Dual PDE4/10A inhibition restores CREB1 function and enhances neuronal resilience in models of alzheimer's disease

  2025cites this paper
• Role and relation of cell death in Alzheimer's disease.

  2025cites this paper
• How Human Induced Pluripotent Stem Cells‐Derived Models can Advance our Understanding of Secretion Mechanisms in Physiological and Pathological Contexts?

  2025cites this paper
• Mutations in specific MT5-MMP domains prevent the accumulation of toxic APP metabolites and serve as templates for peptide-based therapeutics in cell models of Alzheimer’s disease

  2025cites this paper
• Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease

  2025cites this paper
• Longitudinal three-photon imaging for tracking amyloid plaques and vascular degeneration in a mouse model of Alzheimer’s disease

  2025cites this paper
• Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer's disease.

  2025cites this paper
• Modeling neurodegenerative diseases with brain organoids: from development to disease applications

  2025cites this paper
• Neuron-Astrocyte Interactions in Aging and Alzheimer's Disease: Dysregulation of Amyloid Precursor Protein.

  2025cites this paper
• BACE1 at the crossroads of a vicious circle between Alzheimer’s disease and diabetes mellitus

  2025cites this paper
• Genetic risk implicating endolysosomal network genes correlates with endolysosomal dysfunction across neural cell types in Alzheimer’s disease

  2025cites this paper
• Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.

  2025cites this paper
• APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ

  2025influential citation
• Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?

  2025cites this paper
• Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery

  2025cites this paper
• Astrocyte induction of disease-associated microglia is suppressed by acute exposure to fAD neurons in human iPSC triple cultures

  2025cites this paper
• Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis

  2025cites this paper
• Hampered AMPK-ULK1 cascade in Alzheimer’s disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metformin

  2025cites this paper
• Generation of hiPSC-Derived Brain Microvascular Endothelial Cells Using Directed Differentiation and Transcriptional Reprogramming

  2025cites this paper
• γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds

  2025cites this paper
• Small GTPases control macropinocytosis of amyloid precursor protein and cleavage to amyloid-β

  2024cites this paper
• Electroacupuncture regulates Rab5a‐mediating NGF transduction to improve learning and memory ability in the early stage of AD mice

  2024cites this paper
• Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls

  2024cites this paper
• Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells

  2024cites this paper
• Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects

  2024cites this paper
• Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

  2024cites this paper
• Alzheimer’s disease induced neurons bearing PSEN1 mutations exhibit reduced excitability

  2024cites this paper
• APP antisense oligonucleotides reduce amyloid-β aggregation and rescue endolysosomal dysfunction in Alzheimer’s disease

  2024cites this paper
• Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites.

  2024cites this paper
• Deregulation of mitochondrial reverse electron transport alters the metabolism of reactive oxygen species and NAD+/NADH and presents a therapeutic target in Alzheimer’s disease

  2024cites this paper
• A multi-looping chromatin signature predicts dysregulated gene expression in neurons with familial Alzheimer’s disease mutations

  2024influential citation
• A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer’s Disease

  2024cites this paper
• Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

  2024cites this paper
• OCT Imaging in Murine Models of Alzheimer’s Disease in a Systematic Review: Findings, Methodology and Future Perspectives

  2024cites this paper
• Long term rescue of Alzheimer’s deficits in vivo by one-time gene-editing of App C-terminus

  2024cites this paper
• Swedish Alzheimer’s disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways

  2024cites this paper
• Autosomal Dominant Alzheimer’s Disease Mutations in Human Microglia Are Not Sufficient to Trigger Amyloid Pathology in WT Mice but Might Affect Pathology in 5XFAD Mice

  2024cites this paper
• Clathrin mediated endocytosis in Alzheimer's disease: cell type specific involvement in amyloid beta pathology.

  2024cites this paper
• Cell type-specific functions of Alzheimer's disease endocytic risk genes

  2024cites this paper
• Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

  2024cites this paper
• Quantitative analysis of proteostasis networks: are there applications for dementia?

  2024cites this paper
• Altered metabolic function induced by Aβ‐oligomers and PSEN1 mutations in iPSC‐derived astrocytes

  2024cites this paper
• Suppression of MT5-MMP Reveals Early Modulation of Alzheimer’s Pathogenic Events in Primary Neuronal Cultures of 5xFAD Mice

  2024cites this paper
• Amyloid-β is NOT only the most promising target for Alzheimer’s disease

  2024influential citation
• Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer’s disease

  2024cites this paper
• Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer’s disease-relevant brain circuits

  2024cites this paper
• Alzheimer's disease-like pathology induced by Porphyromonas gingivalis in middle-aged mice is mediated by NLRP3 inflammasome via the microbiota-gut-brain axis

  2024cites this paper
• The role of the basal forebrain in the pathogenesis of Alzheimer’s disease

  2024cites this paper
• BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease

  2024cites this paper
• Sequence of Molecular Events in the Development of Alzheimer’s Disease: Cascade Interactions from Beta-Amyloid to Other Involved Proteins

  2024cites this paper
• Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations

  2024cites this paper
• Alzheimer’s Disease Patient Brain Extracts Induce Multiple Pathologies in Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery

  2024cites this paper
• Strategies for modeling aging and age-related diseases

  2024cites this paper
• Differential effects of SORL1 deficiency on the endo-lysosomal network in human neurons and microglia

  2024cites this paper
• Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease.

  2024cites this paper
• Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling

  2024cites this paper
• Approaches for studying neuroimmune interactions in Alzheimer's disease.

  2024cites this paper
• The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer’s Disease

  2023cites this paper
• The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?

  2023cites this paper
• Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy

  2023cites this paper
• Neurodegeneration cell per cell.

  2023cites this paper
• Human neurons lacking amyloid precursor protein exhibit cholesterol-associated developmental and presynaptic deficits

  2023cites this paper
• Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.

  2023cites this paper
• The synthetic TRPML1 agonist ML-SA1 rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system

  2023cites this paper
• Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development.

  2023cites this paper
• On the causal role of retromer-dependent endosomal recycling in Alzheimer’s disease

  2023cites this paper
• Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease

  2023cites this paper
• Amyloid-Beta Peptides Trigger Premature Functional and Gene Expression Alterations in Human-Induced Neurons

  2023cites this paper
• Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer’s disease pathogenesis

  2023cites this paper
• Blockade of mGluR5 in astrocytes derived from human iPSCs modulates astrocytic function and increases phagocytosis

  2023cites this paper